Resveratrol attenuates excessive ethanol exposure induced insulin resistance in rats via improving NAD+ /NADH ratio

Mol Nutr Food Res. 2017 Nov;61(11). doi: 10.1002/mnfr.201700087. Epub 2017 Aug 15.

Abstract

Scope: Resveratrol has been shown to improve insulin resistance via activating the NAD+ -dependent deacetylase SIRT1, but the effects of resveratrol on ethanol-induced insulin resistance remain unclear. This study was designed to explore the potential mechanism by which resveratrol ameliorated ethanol-induced insulin resistance, focusing on its regulations on the ratio of NAD+ /NADH and SIRT1 expression.

Methods and results: Male Sprague-Dawley rats were fed either control or ethanol liquid diets containing 0.8, 1.6 and 2.4 g/kg·bw ethanol with or without 100 mg/kg·bw resveratrol for 22 weeks. Resveratrol improved ethanol (2.4 g/kg·bw) induced reductions in insulin sensitivity, SIRT1 expression (51%, P < 0.05), NAD+ /NADH ratio (196%, P < 0.01) as well as the expression and activity of ALDH2 while decreased the augmentations in the expression and activity of ADH and CYP2E1. In primary rat hepatocytes, ethanol exposure (25 mmol/L, 24 h) similarly decreased SIRT1 expression and NAD+ /NADH ratio (33%, P < 0.05; 32%, P < 0.01), and 0.1 μmol/L resveratrol treatment reversed these decreases and inhibited the expressions of ADH and CYP2E1.

Conclusion: Resveratrol exhibits benefits against ethanol-induced insulin resistance via improving the ratio of NAD+ /NADH to regulate SIRT1, which is associated with the modulation of ethanol metabolism enzymes.

Keywords: Ethanol; Insulin resistance; NAD+; Resveratrol; SIRT1.

MeSH terms

  • Alcohol Dehydrogenase / antagonists & inhibitors
  • Alcohol Dehydrogenase / chemistry
  • Alcohol Dehydrogenase / genetics
  • Alcohol Dehydrogenase / metabolism
  • Aldehyde Dehydrogenase, Mitochondrial / antagonists & inhibitors
  • Aldehyde Dehydrogenase, Mitochondrial / chemistry
  • Aldehyde Dehydrogenase, Mitochondrial / genetics
  • Aldehyde Dehydrogenase, Mitochondrial / metabolism
  • Animals
  • Antioxidants / metabolism
  • Antioxidants / therapeutic use*
  • Cells, Cultured
  • Cytochrome P-450 CYP2E1 / chemistry
  • Cytochrome P-450 CYP2E1 / genetics
  • Cytochrome P-450 CYP2E1 / metabolism
  • Dietary Supplements*
  • Dose-Response Relationship, Drug
  • Ethanol / administration & dosage
  • Ethanol / poisoning
  • Gene Expression Regulation, Enzymologic / drug effects
  • Hepatocytes / drug effects*
  • Hepatocytes / metabolism
  • Hepatocytes / pathology
  • Insulin Resistance*
  • Liver Diseases, Alcoholic / metabolism
  • Liver Diseases, Alcoholic / pathology
  • Liver Diseases, Alcoholic / prevention & control*
  • Male
  • NAD
  • Oxidation-Reduction
  • Oxidative Stress / drug effects*
  • Random Allocation
  • Rats, Sprague-Dawley
  • Resveratrol
  • Signal Transduction / drug effects
  • Sirtuin 1 / antagonists & inhibitors
  • Sirtuin 1 / chemistry
  • Sirtuin 1 / genetics
  • Sirtuin 1 / metabolism
  • Stilbenes / metabolism
  • Stilbenes / therapeutic use*

Substances

  • Antioxidants
  • Stilbenes
  • NAD
  • Ethanol
  • Alcohol Dehydrogenase
  • Cytochrome P-450 CYP2E1
  • Aldehyde Dehydrogenase, Mitochondrial
  • Aldh2 protein, rat
  • Sirt1 protein, rat
  • Sirtuin 1
  • Resveratrol